RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS
Clinical trials for RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS trials appear
Sign up with your email to follow new studies for RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered T-Cells take on tough lymphoma in early trial
Disease control OngoingThis phase I trial tests a new approach for patients with high-risk or recurrent non-Hodgkin lymphoma. After a stem cell transplant, participants receive a single infusion of their own genetically modified T-cells designed to recognize and attack cancer cells. The study aims to f…
Matched conditions: RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New strategy aims to tame common virus after stem cell transplants
Disease control OngoingThis study tests a modified plan to prevent and treat cytomegalovirus (CMV) infection in people with blood cancers who have had a donor stem cell transplant. CMV is a common virus that can cause serious problems after transplant. The study involves 153 participants and looks at w…
Matched conditions: RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC